Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have received a consensus rating of “Moderate Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $16.1250.

Several research analysts recently commented on the stock. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 10th. Wall Street Zen raised shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Finally, Wells Fargo & Company lowered their price objective on Crescent Capital BDC from $14.00 to $13.00 and set an “equal weight” rating on the stock in a report on Friday, February 27th.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. acquired a new stake in Crescent Capital BDC during the 4th quarter worth about $27,000. Rockefeller Capital Management L.P. bought a new position in Crescent Capital BDC during the fourth quarter valued at about $35,000. VPR Management LLC increased its position in shares of Crescent Capital BDC by 150.0% during the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock valued at $71,000 after purchasing an additional 3,000 shares during the period. Westbourne Investments Inc. bought a new position in Crescent Capital BDC during the third quarter worth about $141,000. Finally, Permanens Capital L.P. acquired a new stake in shares of Crescent Capital BDC in the 3rd quarter valued at $147,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Stock Performance

Crescent Capital BDC stock opened at $12.77 on Monday. Crescent Capital BDC has a 1-year low of $12.56 and a 1-year high of $17.97. The firm’s 50 day simple moving average is $13.77 and its 200 day simple moving average is $14.26. The firm has a market capitalization of $471.47 million, a PE ratio of 13.59 and a beta of 0.57. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.24.

Crescent Capital BDC (NASDAQ:CCAP) last posted its earnings results on Wednesday, February 25th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.44 by $0.01. Crescent Capital BDC had a net margin of 20.64% and a return on equity of 9.32%. The firm had revenue of $19.05 million during the quarter, compared to analysts’ expectations of $39.83 million. As a group, analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be paid a $0.42 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.68 dividend on an annualized basis and a yield of 13.2%. Crescent Capital BDC’s payout ratio is currently 178.72%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.